DYAI

DYADIC INTERNATIONAL INC

DYAI·26745T101·US·Common Stock·Healthcare - Biotechnology-13D/G

DYAI (DYADIC INTERNATIONAL INC) is held by 25 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($831,697), TRUIST FINANCIAL CORP ($292,275), GEODE CAPITAL MANAGEMENT, LLC ($224,865). Net institutional sentiment: Mixed.

25
Holders
(3 Elite)
$2.2M
Total Value
64% (14)
Consensus
9 buying - 5 selling
13F: Insider & Congress: Updated regularly
DYAI

Smart Money Verdict

View all
Loading verdict
Held by 25 funds
3 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Jul 24, 2026 · Activists Aug 17, 2026 · Congress none

ActivistFTFrancisco Trust under agreement dated February 28, 199610.3%Aug 17, 2026
InsiderF1Francisco Trust under agreement dated February 28, 1996Sell $3KJul 24, 2026
InsiderF1Francisco Trust under agreement dated February 28, 1996Sell $71KJul 23, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
928,233$831,6970.0%-46.16%
0
Unchanged
326,200$292,2750.0%-74.03%
0
Decreased
250,905(-20.0%)$224,8650.0%-90.68%
0
Decreased
197,749(-28.2%)$177,1830.0%-74.95%
0
Unchanged
139,478$124,9720.0%-46.16%
0
Unchanged
79,469$71,2040.0%-74.43%
0
Decreased
78,786(-3.5%)$70,5920.0%-65.72%
0
New
74,336$66,6050.0%-52.74%
32
Increased
69,745(+112.3%)$62,4920.0%-88.48%
23
Unchanged
53,756$48,1650.0%-76.35%
0
New
46,665$41,8120.0%-52.74%
28
Unchanged
42,550$38,1250.0%-94.62%
0
New
41,217$36,9300.0%-52.74%
31
Increased
34,538(+4.5%)$30,9460.0%-64.71%
14
Unchanged
15,000$13,4400.0%-76.24%
0
Unchanged
12,579$11,2700.0%-87.02%
0
Decreased
11,864(-1.8%)$10,6300.0%-48.22%
0
Unchanged
7,385$6,6170.0%-46.16%
0
Unchanged
4,000$3,5840.0%-91.45%
0
Increased
878(+393.3%)$7870.0%-74.96%
12

Showing 1-20 of 26

1 / 2
DYAIDYAIDYADIC INTERNATIONAL INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used